| Financial Year |
March 31 2023 |
| Monetary Funds |
287,285,748.32 |
| Held-for-trading Financial Assets |
649,486,668.24 |
| Notes Receivable |
-- |
| Accounts Receivable |
213,448,400.01 |
| Advances to Suppliers |
4,860,376.65 |
| Other Receivables |
20,736,443.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
9,497,293.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,414,213.11 |
| Total Current Assets |
1,187,729,143.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,375,673.04 |
| Investment Properties |
-- |
| Fixed Assetes |
16,203,784.51 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
996,615,877.81 |
| R&D expenses |
-- |
| Goodwill |
391,813,474.48 |
| Long-Term Deferred and Prepaid Expenses |
10,165,088.40 |
| Deferred Income Tax Assets |
36,266,420.36 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,486,963,640.28 |
| Total Assets |
2,674,692,783.51 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
7,800,135.10 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,174,123.05 |
| Taxes Payable |
105,768,724.76 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
636,602,214.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
96,235,779.61 |
| Other Current Liabilities |
4,814,386.10 |
| Sub-Total of Current Liabilities |
962,352,927.26 |
| Long-term Loans |
222,600,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
163,074,047.94 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
404,541,350.70 |
| Total Liabilities |
1,366,894,277.96 |
| Paid-In Capital(Or Share Stock) |
822,237,930.00 |
| Capital Surplus |
218,643,502.43 |
| Surplus Reserve |
45,809,069.38 |
| LESS:Treasury Stock |
12,375,000.00 |
| Undistributed Profits |
-618,168,003.17 |
| Minority Stockholder's Interest |
849,035,011.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
458,763,493.94 |
| Owner's Equity（Stockholder's Equity） |
1,307,798,505.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,674,692,783.51 |
